Screening for Silent Atrial Fibrillation During Influenza Vaccination
NCT ID: NCT02006524
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3269 participants
INTERVENTIONAL
2013-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick
NCT02960334
Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick
NCT02270151
Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older
NCT04375241
Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)
NCT02893215
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
NCT04126486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Screening with MyDiagnostick
All patients eligible for influenza vaccination are screened for atrial fibrillation with the MyDiagnostick, an easy to use and patient friendly device.
'MyDiagnostick
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
'MyDiagnostick
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Monika Hollander, MD, PhD
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Tieleman, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Martini Ziekenhuis Groningen
Monika Hollander, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Julius Center UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Practices
Groningen, Provincie Groningen, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace. 2016 Oct;18(10):1514-1520. doi: 10.1093/europace/euv426. Epub 2016 Feb 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-85
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.